Red Blood Cells: Newly Discovered Regulators of Blood Sugar and Potential Diabetes Therapies

For decades, scientists have observed a curious phenomenon: individuals living at high altitudes exhibit lower rates of diabetes compared to those at sea level. Now, groundbreaking research published in Cell Metabolism reveals a key mechanism behind this observation – red blood cells (RBCs) act as a significant glucose sink, particularly under low-oxygen conditions. This discovery not only deepens our understanding of glucose metabolism but also opens new avenues for potential diabetes treatments.

The High-Altitude Paradox and Glucose Control

Epidemiological studies consistently demonstrate improved glucose control in populations residing at altitudes above 3,500 meters, including communities in Tibet, Peru, the United States, and Nepal. Researchers have long known about this correlation, but the underlying biological explanation remained elusive. Even animals adapted to high altitudes show similar metabolic benefits. The paradox lies in the fact that reduced oxygen availability typically impairs metabolic function, yet blood glucose regulation appears enhanced at higher elevations.

How Red Blood Cells Become Glucose Sinks

Researchers at the Gladstone Institutes, utilizing normobaric hypoxia models in mice, found that RBCs adapt to low-oxygen (hypoxic) conditions by dramatically increasing their glucose uptake. This adaptation is multifaceted:

• Increased RBC Numbers: Chronic hypoxia stimulates the production of RBCs, nearly doubling their numbers.
• Enhanced Per-Cell Glucose Uptake: Individual RBCs in hypoxic conditions exhibit a 2.5-fold increase in glucose uptake capacity.
• Upregulation of Glucose Transporters: RBCs increase the expression of GLUT1 and GLUT4, key proteins responsible for transporting glucose across cell membranes.
• Metabolic Rewiring: Glucose metabolism within RBCs is redirected toward 2,3-diphosphoglycerate production via the Luebering-Rapoport shunt, enhancing oxygen release to tissues and simultaneously increasing glucose consumption.
• Molecular Mechanism: Low oxygen conditions displace glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from band 3 protein, accelerating glycolytic flux.

Experiments demonstrated that increasing RBC abundance was both necessary and sufficient to drive the observed improvements in glucose tolerance. Reversing increased RBC numbers through phlebotomy normalized blood glucose levels, while transfusing RBCs from hypoxic donors induced hypoglycemia.

Insulin Independence and Therapeutic Implications

Interestingly, the improved glucose control observed in these studies is largely independent of insulin signaling. While insulin sensitivity wasn’t improved, and was even transiently reduced during hypoxia, the reduction was attributed to a compensatory response to sustained hypoglycemia. This suggests a novel pathway for glucose regulation that bypasses traditional insulin-dependent mechanisms.

The potential therapeutic implications are significant. Researchers found that hypoxia exposure and transfusion of hypoxic RBCs improved hyperglycemia in mouse models of both type 1 and type 2 diabetes. A pharmacologic agent (HypoxyStat) that mimics the effects of hypoxia on hemoglobin oxygen affinity also improved glucose control in a type 2 diabetes model. These findings suggest that modulating RBC metabolism or safely inducing hypoxic adaptations could offer new strategies for managing hyperglycemic conditions.

Future Directions

This research identifies RBCs as previously unrecognized regulators of systemic glucose metabolism. Further investigation is needed to fully elucidate the quantitative flux measurements within RBCs and to explore the long-term effects of manipulating RBC metabolism. However, this discovery represents a paradigm shift in our understanding of glucose homeostasis and provides a promising foundation for the development of innovative therapies for diabetes and other metabolic disorders.